← Leaderboards
Sara Elizabeth Dolan Looby
Massachusetts General Hospital
$2,267,046
Attributed
$4,131,391
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $747.7K · FY2010–25$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,131,391 · 3
By mechanism
R01$3,402,921 · 1
K23$402,701 · 1
R25$325,769 · 1
Top collaborators
- Markella V. Zanni5 shared
- Sara Hurtado Bares2 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Markella V. Zanni$10,033,281
- Joel S Finkelstein$18,947,740
- Gary B. Ruvkun$40,968,557
- James K Pru$5,222,029
- Corrine K Welt$6,308,123
Others in their field
Top investigators on “Menopause”
- Walter C. Willett · Harvard University (Sch Of Public Hlth)$53,296,193
- Howard N Hodis · University Of Southern California$41,393,344
- Maria Mori Brooks · University Of Pittsburgh At Pittsburgh$34,684,572
- Mardge H Cohen · Hektoen Institute For Medical Research$33,499,927
- Maryfran R Sowers · University Of Michigan At Ann Arbor$30,618,230
- Daniel S McConnell · University Of Pittsburgh At Pittsburgh$24,789,449
Research focus
MenopauseAntiretroviral TherapyWomanFutureCaringAgingPublic Health RelevanceInnovationDesignPostmenopauseEvidence BaseEffectivenessGuidelinesHormonesPersonsS HealthAreaUnited StatesEducationProgramsPsychologicNursesQuality Of LifeWomen&Apos
Grant awards (10)
EMPOWHer: Embracing Midlife & Menopause Positively-Offerings by Women with HIV$161,798
R25 · FY2025 · LM · contact PI
EMPOWHer: Embracing Midlife & Menopause Positively-Offerings by Women with HIV$163,971
R25 · FY2024 · LM · contact PI
Cardiovascular Disease Risk in HIV-infected Women: Sex-Specific Mechanisms of Risk and Risk Reduction among REPRIEVE Trial Participants$743,401
R01 · FY2019 · AI
Cardiovascular Disease Risk in HIV-infected Women: Sex-Specific Mechanisms of Risk and Risk Reduction among REPRIEVE Trial Participants$740,154
R01 · FY2018 · AI
Cardiovascular Disease Risk in HIV-infected Women: Sex-Specific Mechanisms of Risk and Risk Reduction among REPRIEVE Trial Participants$738,035
R01 · FY2017 · AI
Cardiovascular Disease Risk in HIV-infected Women: Sex-Specific Mechanisms of Risk and Risk Reduction among REPRIEVE Trial Participants$747,720
R01 · FY2016 · AI
Cardiovascular Disease Risk in HIV-infected Women: Sex-Specific Mechanisms of Risk and Risk Reduction among REPRIEVE Trial Participants$433,611
R01 · FY2015 · AI
Metabolic and Psychosocial Changes Associated with Menopause among Women with HIV$134,033
K23 · FY2012 · NR · contact PI
Metabolic and Psychosocial Changes Associated with Menopause among Women with HIV$134,325
K23 · FY2011 · NR · contact PI
Metabolic and Psychosocial Changes Associated with Menopause among Women with HIV$134,343
K23 · FY2010 · NR · contact PI